We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global ELISA Analyzers Market Driven by Demand for Technologically Advanced Immunological Tools

By LabMedica International staff writers
Posted on 30 Oct 2023
Print article
Image: The global ELISA analyzers market is expected to register an impressive CAGR during the 2024-2028 forecast period (Photo courtesy of 123RF)
Image: The global ELISA analyzers market is expected to register an impressive CAGR during the 2024-2028 forecast period (Photo courtesy of 123RF)

Enzyme-Linked Immunosorbent Assay, commonly known as ELISA, is a laboratory test used for detecting antibodies in the blood. ELISA tests operate on the interaction between antibodies and antigens, making it useful for diagnosing diseases. Automated instruments, or analyzers, carry out various steps of the test, ensuring both accuracy and consistent results. As the incidence of diseases like cancer, hepatitis, and HIV rises globally, there is a growing need for diagnostic tools like ELISA, thereby boosting the market for ELISA analyzers. The global ELISA analyzers market is projected to grow at an impressive rate from 2024 to 2028, due to the increasing demand for reliable infectious disease tests and the growing need for technologically advanced diagnostic tools.

These are the latest findings of Research and Markets (Ireland, UK), a provider of market research reports.

Analyzers are engineered to meet specific requirements for running immunological tests, such as maintaining test sensitivity, reducing background noise, and ensuring quick and consistent outcomes. Some modern ELISA analyzers, like open-system automated analyzers, come with pre-set testing options and easy-to-follow guides, simplifying the setup process and making it more convenient for users. Innovations in automation, like increased walkaway time and throughput, are also minimizing the labor-intensive aspects of handling large samples, which is anticipated to further drive market growth in the coming years.

In addition, their ability to measure enzyme activity and detect soluble proteins and cytokines is also increasing the demand for ELISA analyzers. The rise in allergy cases is spurring a need for diagnostic techniques, including ELISA, which is frequently employed for identifying food allergies. The indirect IgE-ELISA method is commonly used for detecting specific allergen-related IgE in blood serum due to its cost-effectiveness and simplicity compared to other systems. ELISA also has applications in measuring antibody levels used for assessing vaccine effectiveness, resulting in growing demand from companies that are at the forefront of vaccine development.

Related Links:
Research and Markets

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.